Specialist physicians are the most valuable and hardest-to-reach audience in healthcare market research. TFSurvey maintains deep, NPI-verified specialty cohorts across 30+ medical disciplines — protected by the CalibraSync triple-layer verification stack that professional impostors cannot defeat.
TFSurvey maintains dedicated, proportionally representative cohorts within each specialty — including hard-to-reach sub-specialties that most panels can't deliver reliably.
The more specialized the target audience, the higher the survey incentive — and the higher the incentive, the more aggressively professional respondents target that audience. Oncologists and interventional cardiologists attract the highest B2C-equivalent incentives in healthcare research.
A screener asking "Are you a board-certified oncologist?" is trivially defeated by anyone who knows the right answer. TFSurvey's three-layer verification — NPI lookup, board certification check, behavioral biometrics — creates a checkpoint that professional impostors cannot pass.
See Full Verification Architecture →Active license, specialty code, and practice state verified against the federal NPI registry in real time.
ABMS and equivalent international board certification status confirmed for every specialist panelist — not just claimed specialty.
Continuous behavioral biometrics ensure the verified specialist is the actual survey participant — not an assistant or delegated responder.
Not just "oncologist" — interventional vs. medical vs. radiation oncology. TFSurvey's sub-specialty granularity enables studies that generic panels simply can't execute accurately.
Deep specialty cohorts mean even low-incidence targets (pediatric oncology, transplant surgery, behavioral neurology) can be fielded within standard project timelines — no extraordinary recruitment fees.
Every specialist respondent carries a full NPI verification audit trail. For pharmaceutical and medical device research requiring regulatory documentation, TFSurvey's data is built to withstand scrutiny.